ADCT vs CLOV
ADC Therapeutics SA (ADCT) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
ADC Therapeutics SA (ADCT) is a biotechnology company listed on NYSE.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported ADCT revenue for 2024-12-31 was $70.8M. Net income was -$157.8M. Revenue was up 1.8% from 2023-12-31 to 2024-12-31. ADCT currently screens at market cap $141.2M.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
ADCT currently screens at market cap $141.2M. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the ADCT and CLOV stock pages for the full models.
Not investment advice.